AM

Atsuhiko Maeda

CP Chugai Pharmaceutical: 26 patents #5 of 1,238Top 1%
Overall (All Time): #149,933 of 4,157,543Top 4%
26
Patents All Time

Issued Patents All Time

Showing 1–25 of 26 patents

Patent #TitleCo-InventorsDate
12371485 Antigen-binding molecule inducing immune response to target antigen Tomoyuki Igawa, Kenta Haraya, Tatsuhiko Tachibana 2025-07-29
12269876 Modified Fc region of antibody Taichi Kuramochi, Meiri Kawazoe, Futa Mimoto, Tomoyuki Igawa 2025-04-08
11891434 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly Tomoyuki Igawa, Shinya Ishii, Miho Funaki, Naoka Hironiwa, Junichi Nezu +3 more 2024-02-06
11827699 Methods for producing antibodies promoting disappearance of antigens having plurality of biological activities Tomoyuki Igawa, Shigero Tamba, Takehisa Kitazawa, Takeshi Baba, Yoshinao Ruike +1 more 2023-11-28
11718678 Method for altering plasma retention and immunogenicity of antigen-binding molecule Tomoyuki Igawa, Kenta Haraya, Yuki Iwayanagi, Tatsuhiko Tachibana, Futa Mimoto +3 more 2023-08-08
11371039 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly Tomoyuki Igawa, Shinya Ishii, Takashi Nakai 2022-06-28
11359194 Antigen-binding molecule capable of binding two or more antigen molecules repeatedly Tomoyuki Igawa, Shinya Ishii, Takashi Nakai 2022-06-14
11180548 Methods of neutralizing IL-8 biological activity Tomoyuki Igawa, Kenta Haraya, Tatsuhiko Tachibana, Yuki Iwayanagi, Yuji Hori +2 more 2021-11-23
11059881 Method for measuring viscosity of protein solution Masakazu Fukuda, Akira Hayasaka, Tomoyuki Igawa, Machiko Fujino 2021-07-13
10662245 Methods of reducing IL-6 activity for disease treatment Tomoyuki Igawa, Shinya Ishii, Mika Sakurai, Tetsuo Kojima, Tatsuhiko Tachibana +3 more 2020-05-26
10618965 Method for altering plasma retention and immunogenicity of antigen-binding molecule Tomoyuki Igawa, Kenta Haraya, Yuki Iwayanagi, Tatsuhiko Tachibana, Futa Mimoto +3 more 2020-04-14
10556949 Antigen-binding molecule inducing immune response to target antigen Tomoyuki Igawa, Kenta Haraya, Tatsuhiko Tachibana 2020-02-11
10519229 Nucleic acids encoding IL-8 antibodies Tomoyuki Igawa, Kenta Haraya, Tatsuhiko Tachibana, Yuki Iwayanagi, Yuji Hori +2 more 2019-12-31
10472623 Antigen-binding molecule capable of binding two or more antigen molecules repeatedly Tomoyuki Igawa, Shinya Ishii, Takashi Nakai 2019-11-12
10435458 Antibody constant region variants with reduced Fcgammar binding Taichi Kuramochi, Tomoyuki Igawa, Futa Mimoto 2019-10-08
10253100 Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance Tomoyuki Igawa, Futa Mimoto, Taichi Kuramochi 2019-04-09
10253091 Antibody constant region variant Tomoyuki Igawa, Taichi Kuramochi, Hirotake Shiraiwa 2019-04-09
10150808 Modified antibody constant regions Taichi Kuramochi, Shigero Tanba, Tomoyuki Igawa, Kiyoaki Sakata, Mika Endoh 2018-12-11
10066018 Antibody constant region variant Tomoyuki Igawa, Hirotake Shiraiwa 2018-09-04
9969800 IL-8 antibodies Tomoyuki Igawa, Genki Nakamura, Masaru Muraoka 2018-05-15
9890377 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly Tomoyuki Igawa, Shinya Ishii, Takashi Nakai 2018-02-13
9868948 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly Tomoyuki Igawa, Shinya Ishii, Takashi Nakai 2018-01-16
9556264 Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient Hirotake Shiraiwa, Keiko Esaki, Tomoyuki Igawa, Taichi Kuramochi, Shigero Tamba +8 more 2017-01-31
9340615 Anti-AXL antibody Hajime Miyamoto, Taichi Kuramochi, Atsushi Matsuo, Tomoyuki Igawa, Hirotake Shiraiwa +2 more 2016-05-17
9228017 Antibody constant region variant Tomoyuki Igawa, Hirotake Shiraiwa 2016-01-05